190 related articles for article (PubMed ID: 6279146)
1. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
Macfarlane DE; Mills DC; Srivastava PC
Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
[No Abstract] [Full Text] [Related]
2. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
3. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).
Haslam RJ; Vanderwel M
J Biol Chem; 1982 Jun; 257(12):6879-85. PubMed ID: 6177688
[No Abstract] [Full Text] [Related]
5. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of ADP receptors.
Cusack NJ; Hourani SM; Welford LA
Adv Exp Med Biol; 1985; 192():29-39. PubMed ID: 3010670
[No Abstract] [Full Text] [Related]
7. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
Farndale RW; Winkler AB; Martin BR; Barnes MJ
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
Clare KA; Scrutton MC; Thompson NT
Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase.
Jaschonek K; Faul C; Schmidt H; Renn W
Eur J Pharmacol; 1988 Mar; 147(2):187-96. PubMed ID: 2452749
[TBL] [Abstract][Full Text] [Related]
10. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
11. The role of GTP in prostaglandin E1 stimulation of adenylate cyclase in platelet membranes.
Stein JM; Martin BR
Biochem J; 1983 Jul; 214(1):231-4. PubMed ID: 6684425
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP metabolism in cholesterol-rich platelets.
Sinha AK; Shattil SJ; Colman RW
J Biol Chem; 1977 May; 252(10):3310-4. PubMed ID: 193833
[No Abstract] [Full Text] [Related]
13. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
[TBL] [Abstract][Full Text] [Related]
14. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
Haslam RJ; Rosson GM
Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
[No Abstract] [Full Text] [Related]
15. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
Hall DA; Hourani SM
Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
[TBL] [Abstract][Full Text] [Related]
16. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets.
Reches A; Eldor A; Salomon Y
Thromb Res; 1979; 16(1-2):107-16. PubMed ID: 228444
[No Abstract] [Full Text] [Related]
17. Identification of a receptor for ADP on blood platelets by photoaffinity labelling.
Cristalli G; Mills DC
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):875-81. PubMed ID: 8387782
[TBL] [Abstract][Full Text] [Related]
18. Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats.
Tremblay J; Hamet P
Metabolism; 1984 Aug; 33(8):689-95. PubMed ID: 6087083
[TBL] [Abstract][Full Text] [Related]
19. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
20. Effects of protein kinase C activation on human platelet cyclic AMP metabolism.
Bushfield M; Hopple SL; Gibson IF; Murdoch FA; MacIntyre DE
FEBS Lett; 1987 Oct; 222(2):299-304. PubMed ID: 2820806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]